Literature DB >> 16291765

Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia.

Myriam Arévalo-Herrera1, Yezid Solarte, Felipe Zamora, Fabián Mendez, Maria Fernanda Yasnot, Leonardo Rocha, Carole Long, Louis H Miller, Sócrates Herrera.   

Abstract

Plasmodium vivax transmission-blocking activity was assessed in sera from acutely infected patients from a malaria-endemic area in Colombia. We measured reduction in the number of oocysts that developed in the midguts of Anopheles albimanus mosquitoes artificially fed with blood from these patients. Of 88 mosquito batches that developed infections when parasites were mixed with normal AB human serum, one-third (36.4%) showed full transmission-blocking activity (>or= 90% inhibition) when mixed with autologous sera, 29.6% showed partial activity (50-89%), 17.0% did not block transmission (0-50%), and 17% did not enhance transmission. Transmission-blocking activity correlated with antibody titer by an immunofluorescent antibody test and decreased with the serial dilution of the sera. This activity disappeared at a 1:4 dilution in most sera tested. Afro-Colombian individuals showed lower activity than other ethnic groups and febrile patients produced stronger inhibition than those without fever.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291765     DOI: 10.4269/ajtmh.2005.73.5_suppl.0730038

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

Review 1.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 2.  Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Catherin Marin; Mariana Santos; Jenniffer Castellanos; John C Beier; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

3.  Targeting molecular interactions essential for Plasmodium sexual reproduction.

Authors:  Joel Vega-Rodriguez; Davinia Perez-Barreto; Antonio Ruiz-Reyes; Marcelo Jacobs-Lorena
Journal:  Cell Microbiol       Date:  2015-05-29       Impact factor: 3.715

4.  Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Leonardo Rocha; Diego Alvarez; John C Beier; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

5.  Plasmodium vivax sporozoite production in Anopheles albimanus mosquitoes for vaccine clinical trials.

Authors:  Yezid Solarte; María R Manzano; Leonardo Rocha; Hugo Hurtado; Mark A James; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

6.  Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice.

Authors:  Myriam Arévalo-Herrera; Kazutoyo Miura; Eduardo Solano; Juan Sebastián Ramírez; Carole A Long; Giampietro Corradin; Sócrates Herrera
Journal:  Vaccine       Date:  2021-11-19       Impact factor: 3.641

7.  Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.

Authors:  Fei Liu; Li Li; Wenqi Zheng; Yiwen He; Yaru Wang; Xiaotong Zhu; Takafumi Tsuboi; Liwang Cui; Meilian Wang; Yaming Cao
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

8.  Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes.

Authors:  Myriam Arévalo-Herrera; Andrés F Vallejo; Kelly Rubiano; Yezid Solarte; Catherin Marin; Angélica Castellanos; Nora Céspedes; Sócrates Herrera
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

9.  The Plasmodium bottleneck: malaria parasite losses in the mosquito vector.

Authors:  Ryan C Smith; Joel Vega-Rodríguez; Marcelo Jacobs-Lorena
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08       Impact factor: 2.743

10.  Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems.

Authors:  Myriam Arévalo-Herrera; Kazutoyo Miura; Nora Cespedes; Carlos Echeverry; Eduardo Solano; Angélica Castellanos; Juan Sebastián Ramirez; Adolfo Miranda; Andrey V Kajava; Carole Long; Giampietro Corradin; Sócrates Herrera
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.